Afghanistan vs Bahrain: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Bahrain
100.0%
in 2023
Afghanistan rank
1st
Bahrain rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Bahrain
How they compare
Afghanistan currently reports 100.0% against 100.0% in Bahrain, a difference of 0.0%.
The two have swapped places 5 times across 11 shared years of data; in 2009 it was Afghanistan ahead.
Afghanistan ranks 1st and Bahrain ranks 1st of 144 countries.
Afghanistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Bahrain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 12.0% | 88.0% | Afghanistan |
| 2010s | 71.7% | 66.2% | 5.5% | Afghanistan |
| 2020s | 100.0% | 57.5% | 42.5% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Bahrain?
- Afghanistan, at 100.0% against 100.0% in Bahrain as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Bahrain?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Bahrain?
- 11 years are reported by both, from 2009 to 2023.
- How do Afghanistan and Bahrain rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Bahrain ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.